A Study on the Safety and Immune Responses to the GVGH altSonflex1-2-3 Vaccine Against Shigellosis in Adults, Children, and Infants
Clinical trial NCT05073003 · COMPLETED
Trial details
- NCT number
- NCT05073003
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-06
- Primary completion
- 2025-06-24
- Enrollment
- 551
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.